Background & Aims There has been increased attention on ways to improve the quality of
end-of-life care for patients with end-stage liver disease; however, there have been few …

Patients with end‐stage liver disease (ESLD) often have a high symptom burden.
Historically, palliative care (PC) services have been underused in this population. We …

Objective To identify the limitations in palliative care provision in the last year of life for
people with liver cirrhosis and potential barriers to and enablers of palliative care. Design …

Objectives To understand patterns of care and end-of-life preferences for patients dying with
end stage liver disease with cirrhosis (ESLDC). Methods Data were collected during the …

AIM To evaluate use of palliative care services in patients with end-stage liver disease who
do not have access to liver transplant. METHODS Evaluated were end-stage liver disease …

Optimal involvement of palliative care (PC) services in the management of patients with
decompensated cirrhosis and end‐stage liver disease (ESLD) is limited. This may result …

Context Palliative care interventions have shown promise in improving quality of life and
reducing health-care utilization among patients with chronic organ failure. Objectives To …

Decompensated cirrhosis is an illness that causes tremendous suffering. The incidence of
cirrhosis is increasing and rates of liver transplant, the only cure, remain stagnant. Palliative …

End‐stage liver disease (ESLD) is associated with a high degree of morbidity and mortality
as well as symptom burden. Despite this, the rate of consultation with palliative care (PC) …

The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with
advanced disease have a symptom burden comparable to or higher than that experienced …